PF-Atlas › Clinical Trials › NCT07876284
A Study to Assess the Safety, Tolerability and Pharmacokinetics of Repeated Doses of Inhaled CHF10073 in Participants With Idiopathic Pulmonary Fibrosis
CHF10073 low dose · Phase 1
Registry ID
NCT07876284
Phase
Phase 1
Status
Not yet recruiting
Drug / intervention
CHF10073 low dose
Sponsor
Chiesi Farmaceutici S.p.A.
Enrollment
18
About this trial
The objective of the study is to assess the safety and tolerability of repeated doses of CHF10073 and to characterise cough-related safety outcomes associated with CHF10073 administration. In addition, the study will also characterise the PK (pharmacokinetics) profile in plasma after repeated administrations of study drug.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT07876284 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.